# Gene Discovery in CHB Patients to Identify Unknown Pathways That Lead to B and NK Cell Deregulation

> **NCT06853886** · NA · RECRUITING · sponsor: **University Hospital, Limoges** · enrollment: 140 (estimated)

## Conditions studied

- Chronic Hepatitis B Virus

## Interventions

- **OTHER:** blood sample HBV patient
- **OTHER:** blood sample healthy volunteers

## Key facts

- **NCT ID:** NCT06853886
- **Lead sponsor:** University Hospital, Limoges
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-12
- **Primary completion:** 2028-10-01
- **Final completion:** 2028-10-01
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2025-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06853886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06853886, "Gene Discovery in CHB Patients to Identify Unknown Pathways That Lead to B and NK Cell Deregulation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06853886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*